SPI
16.157,82
PKT
+157,60
PKT
+0,98
%
Werbung
Analysen zu SPI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.09.05 | Adecco SA equal-weight | Morgan Stanley | |
28.09.05 | UBS akkumulieren | Independent Research | |
23.09.05 | Novartis | DZ-Bank | |
23.09.05 | Clariant halten | Hamburger Sparkasse | |
27.09.05 | Novartis buy | Jyske Bank | |
23.09.05 | Novartis outperform | HypoVereinsbank | |
22.09.05 | Swiss Life | Focus Money | |
21.09.05 | Novartis neutral | Bank Sarasin & Cie | |
22.09.05 | Novartis kaufen | Helaba Trust | |
21.09.05 | Novartis akkumulieren | Independent Research | |
22.09.05 | Holcim | Helaba Trust | |
20.09.05 | Novartis akkumulieren | Independent Research | |
21.09.05 | dormakaba neutral | Bank Sarasin & Cie | |
16.09.05 | Zurich Insurance halten | Helaba Trust | |
16.09.05 | Novartis | DZ-Bank | |
16.09.05 | Holcim kaufen | Helaba Trust | |
16.09.05 | Holcim verkaufen | Helaba Trust | |
16.09.05 | Lonza overweight | JP Morgan | |
20.09.05 | Novartis buy | Jyske Bank | |
15.09.05 | Novartis halten | Wertpapier | |
15.09.05 | Zurich Insurance outperform | WestLB | |
14.09.05 | Richemont outperform | Goldman Sachs | |
12.09.05 | Holcim overweight | JP Morgan | |
09.09.05 | Novartis hold | Deutsche Bank | |
09.09.05 | ABB (Asea Brown Boveri) kaufen | Der Aktionärsbrief | |
09.09.05 | Novartis buy | A.G. Edwards & Sons | |
08.09.05 | UBS equal-weight | Morgan Stanley | |
08.09.05 | UBS overweight | Morgan Stanley | |
08.09.05 | Holcim akkumulieren | Independent Research | |
08.09.05 | Novartis Buy | AG Edwards | |
08.09.05 | Holcim halten | Helaba Trust | |
06.09.05 | ABB (Asea Brown Boveri) halten | Helaba Trust | |
05.09.05 | Geberit halten | Öko Invest | |
05.09.05 | UBS kaufen | Weberbank | |
05.09.05 | Nestlé kaufen | Weberbank | |
05.09.05 | Novartis | Weberbank | |
05.09.05 | UBS halten | Helaba Trust | |
05.09.05 | UBS akkumulieren | Independent Research | |
05.09.05 | UBS buy | SEB | |
05.09.05 | Nestlé overweight | Morgan Stanley |